Two Sigma Investments
ENZ

Two Sigma Investments’s Enzo Biochem, Inc. ENZ Stock Holding History

Two Sigma Investments’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-42,327
Closed -$150K – 5004
2021
Q3 		$150K Sell
42,327
-11,637
-22% -$38.8K ﹤0.01% 4022
2021
Q2 		$171K Buy
53,964
+11,105
+26% +$34.9K ﹤0.01% 3818
2021
Q1 		$147K Buy
+42,859
New +$133K ﹤0.01% 3675
2020
Q1 		– Sell
-116,190
Closed -$306K – 3941
2019
Q4 		$306K Sell
116,190
-46,421
-29% -$139K ﹤0.01% 3175
2019
Q3 		$585K Buy
162,611
+57,288
+54% +$203K ﹤0.01% 2426
2019
Q2 		$355K Buy
105,323
+36,159
+52% +$127K ﹤0.01% 2761
2019
Q1 		$189K Sell
69,164
-56,398
-45% -$185K ﹤0.01% 2830
2018
Q4 		$349K Buy
125,562
+17,823
+17% +$58.4K ﹤0.01% 2351
2018
Q3 		$444K Buy
107,739
+31,929
+42% +$145K ﹤0.01% 2539
2018
Q2 		$393K Buy
75,810
+7,434
+11% +$45.3K ﹤0.01% 2782
2018
Q1 		$375K Buy
68,376
+34,916
+104% +$246K ﹤0.01% 2656
2017
Q4 		$273K Buy
33,460
+22,323
+200% +$213K ﹤0.01% 2774
2017
Q3 		$117K Sell
11,137
-177,248
-94% -$1.97M ﹤0.01% 2639
2017
Q2 		$2.08M Buy
188,385
+26,350
+16% +$246K 0.01% 1393
2017
Q1 		$1.36M Buy
162,035
+54,282
+50% +$382K ﹤0.01% 1715
2016
Q4 		$748K Sell
107,753
-52,849
-33% -$337K ﹤0.01% 2217
2016
Q3 		$817K Sell
160,602
-45,915
-22% -$274K ﹤0.01% 2113
2016
Q2 		$1.23M Buy
206,517
+115,928
+128% +$643K 0.01% 1592
2016
Q1 		$412K Buy
90,589
+15,531
+21% +$69.1K ﹤0.01% 2184
2015
Q4 		$338K Buy
+75,058
New +$317K ﹤0.01% 2182
2015
Q3 		– Sell
-21,194
Closed -$64K – 2830
2015
Q2 		$64K Sell
21,194
-13,689
-39% -$38.5K ﹤0.01% 2732
2015
Q1 		$103K Buy
+34,883
New +$114K ﹤0.01% 2545
2014
Q3 		– Sell
-21,900
Closed -$115K – 2107
2014
Q2 		$115K Buy
+21,900
New +$94.7K ﹤0.01% 2043
2014
Q1 		– Sell
-108,772
Closed -$317K – 2310
2013
Q4 		$317K Buy
108,772
+83,028
+323% +$206K ﹤0.01% 1857
2013
Q3 		$65K Buy
+25,744
New +$61K ﹤0.01% 1774

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's ENZ Position: Q4 2021 in Review

Two Sigma Investments sold out of Enzo Biochem, Inc. (ENZ) in Q4 2021, closing a stake of 42,327 shares — an estimated $150K sold.

Two Sigma Investments first reported a position in ENZ in Q3 2013 and held it in 25 quarters. The position peaked at $2.08M in Q2 2017. 59 funds tracked by Wall St. Rank hold ENZ as of Q4 2021.

  • Two Sigma Investments reported no remaining Enzo Biochem, Inc. position as of Q4 2021 after selling out during the quarter.
  • Two Sigma Investments sold 42,327 Enzo Biochem, Inc. shares in Q4 2021, an estimated $150K.
  • Two Sigma Investments first reported a position in Enzo Biochem, Inc. in Q3 2013 and held it in 25 quarters.
  • Two Sigma Investments's Enzo Biochem, Inc. position peaked at $2.08M in Q2 2017.
  • 59 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2021.

Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.